论文部分内容阅读
静脉输液是临床工作中主要治疗手段。静脉输液从药物配制到给药的过程中,均需要严格执行无菌技术操作和消毒隔离制度,以及还要遵循不同药物间的配伍禁忌。我科在2013年2月用药过程中发现硫酸依替米星注射液(商品名:悉能)与注射用甲泼尼琥珀酸钠(商品名:甲强龙)二者配伍时,液体立即出现乳白色混浊伴沉淀物形成。因此,我科进行了试验及观察,以指导二种药物的正确使用,从而达到其治疗效果。具体报道如下:
Intravenous infusion is the main treatment in clinical work. Intravenous infusion from the drug preparation to the process of administration, are required to strictly implement the aseptic technique and disinfection and isolation system, and also to follow the compatibility of different drugs taboo. My department in February 2013 medication found in the etimicin sulfate injection (trade name: can be) and injection of methyl prednisolone sodium (trade name: methylprednisolone) both compatibility, the liquid immediately Milky white with precipitate formation. Therefore, our department conducted experiments and observations to guide the correct use of the two drugs, so as to achieve its therapeutic effect. Specific reports are as follows: